Literature DB >> 11006216

Ascorbic acid concentration and total antioxidant activity of human tear fluid measured using the FRASC assay.

C K Choy1, I F Benzie, P Cho.   

Abstract

PURPOSE: To evaluate a novel method (FRASC) for total ferric reducing (antioxidant) activity and ascorbic acid concentration applied to human tears, to investigate the stability of ascorbic acid, and to determine the antioxidant status of human reflex tears.
METHODS: Linearity, sensitivity, and precision of FRASC and ascorbic acid loss during 7 days' storage were assessed; total antioxidant activity and ascorbic acid and uric acid concentrations of reflex tears from 47 healthy subjects were measured.
RESULTS: FRASC has good precision, linearity, and sensitivity. Ascorbic acid is stable for at least 7 days at moderately acidic pH (pH 3.6) and low temperature. Total antioxidant activity and ascorbic acid and uric acid concentrations (mean +/- SD) in reflex tears were 409 +/- 162, 23 +/- 9.6, and 68 +/- 46 microM, respectively. Ascorbic acid and uric acid constituted around half the total antioxidant activity measured. There was a significant correlation between uric acid and total antioxidant activity (r = 0.754; P: < 0.0001). Men had significantly (P: = 0.0045) higher tear ascorbic acid concentrations than women.
CONCLUSIONS: FRASC is suitable for measuring total antioxidant activity and ascorbic acid in human tears. Further clinical study is needed to investigate the male-female difference seen, to characterize the remaining 50% antioxidant activity, and to investigate the effects of environmental conditions, antioxidant supplementation, age, and ocular disease on tear antioxidant status.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006216

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

1.  Iodide iontophoresis as a treatment for dry eye syndrome.

Authors:  J Horwath-Winter; O Schmut; E-M Haller-Schober; A Gruber; G Rieger
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

2.  Activity-Based Sensing of Ascorbate by Using Copper-Mediated Oxidative Bond Cleavage.

Authors:  Zuo Hang Yu; Christopher J Reinhardt; Thomas Hin-Fung Wong; Ka Yan Tong; Jefferson Chan; Ho Yu Au-Yeung
Journal:  Chemistry       Date:  2020-06-25       Impact factor: 5.236

3.  Iodide protection from UVB irradiation-induced degradation of hyaluronate and against UVB-damage of human conjunctival fibroblasts.

Authors:  Otto Schmut; Jutta Horwath-Winter; Gebhard Rieger; Rudolf Winkler; Gabriele Trummer; Helga Spitzenberger; Christa Wachswender
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-16       Impact factor: 3.117

4.  Protective role of oral antioxidant supplementation in ocular surface of diabetic patients.

Authors:  V Peponis; M Papathanasiou; A Kapranou; C Magkou; A Tyligada; A Melidonis; T Drosos; N M Sitaras
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

5.  Simple and rapid method for the determination of uric acid-independent antioxidant capacity.

Authors:  Darko Duplancic; Lea Kukoc-Modun; Darko Modun; Njegomir Radic
Journal:  Molecules       Date:  2011-08-17       Impact factor: 4.411

6.  Changes in the Selected Antioxidant Defense Parameters in the Blood of Patients after High Resolution Computed Tomography.

Authors:  Amira Bryll; Wirginia Krzyściak; Anna Jurczak; Robert Chrzan; Anna Lizoń; Andrzej Urbanik
Journal:  Int J Environ Res Public Health       Date:  2019-04-26       Impact factor: 3.390

7.  Tear ascorbic acid levels and the total antioxidant status in contact lens wearers: a pilot study.

Authors:  Sai Jyothi Aluru Venkata; Angayarkanni Narayanasamy; Vidhya Srinivasan; Geetha Krishnan Iyer; Ramakrishnan Sivaramakrishnan; Madhumathi Subramanian; Rajeshwari Mahadevan
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

8.  Point-of-service, quantitative analysis of ascorbic acid in aqueous humor for evaluating anterior globe integrity.

Authors:  Manas R Gartia; Santosh K Misra; Mao Ye; Aaron Schwartz-Duval; Lisa Plucinski; Xiangfei Zhou; David Kellner; Leanne T Labriola; Dipanjan Pan
Journal:  Sci Rep       Date:  2015-11-03       Impact factor: 4.379

9.  Surface-enhanced Raman spectroscopy of tears: toward a diagnostic tool for neurodegenerative disease identification.

Authors:  Gilda Cennamo; Daniela Montorio; Vincenzo Brescia Morra; Chiara Criscuolo; Roberta Lanzillo; Elena Salvatore; Carlo Camerlingo; Mikhail Lisitskiy; Ines Delfino; Marianna Portaccio; Maria Lepore
Journal:  J Biomed Opt       Date:  2020-08       Impact factor: 3.170

10.  A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome.

Authors:  Yoon-Ju Na; Kyoung Jin Choi; Won Hoon Jung; Sung Bum Park; Sein Kang; Jin Hee Ahn; Ki Young Kim
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.